Article Details

Ketamine Beating Psilocybin in Race for Patients

Retrieved on: 2020-11-23 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

Ketamine Beating Psilocybin in Race for Patients. View article details on hiswai:

Excerpt

In May the <b>shares</b> were trading at a price over $1, but they have since fallen to roughly 50 cents per share. Champignon also plans to acquire <b>Canadian</b> ketamine clinic operator AltMed Capital Corp. Champignon said that AltMed ...

Article found on: realmoney.thestreet.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up